Shivalingappa, Pavan Kumar Mysuru
Singh, Divya Kumari
Sharma, Vaishali
Arora, Vivek
Shiras, Anjali
Bapat, Sharmila A. http://orcid.org/0000-0002-9557-2233
Funding for this research was provided by:
Department of Biotechnology, Ministry of Science and Technology, India (BT/PR15178/MED/31/313/2015, BT/PR15178/MED/31/313/2015)
University Grants Commission - India (Research Fellowship)
Department of Biotechnology, Government of India (Research Fellowship)
Indian Council of Medical Research (Research Fellowship)
Article History
Accepted: 3 August 2022
First Online: 20 August 2022
Declarations
:
: Experiments on pluripotent stem cells (ESCs/iPSCs) were in compliance with the National Guidelines for Stem Cell Research (2013 & 2017) and ethical approval was granted by NCCS Institutional Committee for Stem Cell Research (ID: NCCS/IC-SCR/2016-I/3). Animal experiments were carried out as per CPCSEA guidelines and ethical approval was granted by the Institute’s Animal Ethics Committee (ID: EAF/2015/B-253 & EAF/2019/B-351). Recombinant DNA technology used in the study was in compliance with Guidelines for Biosafety from Department of Biotechnology and ethical approval was granted by the Institutional Biosafety Committee (ID: 2015033 & 2018111).
: The authors have no financial or proprietary interests in any material discussed in this article.
Free to read: This content has been made available to all.